Literature DB >> 448111

Evidence for a common mucosal immunologic system. I. Migration of B immunoblasts into intestinal, respiratory, and genital tissues.

M R McDermott, J Bienenstock.   

Abstract

The origins of immunoglobulin-containing cells in intestinal, respiratory, mammary, and genital tissues were studied in CBA/J female mice by using an adoptive lymphocyte transfer method. Within 24 hr after transfer, [3H]thymidine-labeled donor mesenteric lymph node (MLN) cells were observed in recipient gut, cervix and vagina, uterus, mammary glands, and MLN, where approximately 60% contained IgA and 25% IgG. In peripheral lymph nodes (PLN), 44% of the labeled cells after MLN transfer contained IgG, whereas only 8% were of the IgA isotype. The preference of the MLN to populate mucosal sites was clear from the results. Labeled PLN cells were transferred and the majority of these returned to their sites of origin and contained IgG. Of the small number of labeled PLN cells found in mucosal tissues, approximately equal percentages (30%) of IgA- anti IgG-containing cells were seen. Dividing cells prepared from mediastinal (bronchial) lymph nodes (BLN) showed a propensity to localize in the lungs rather than the intestine. However, the predominant immunoglobulin content of these donor cells in gut, lungs, and MLN was IgA. In recipient PLN, most labeled BLN cells contained IgG. These data support the concept of a common mucosal immunologic system.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 448111

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  194 in total

Review 1.  Molecules controlling lymphocyte migration to the gut.

Authors:  M Salmi; S Jalkanen
Journal:  Gut       Date:  1999-07       Impact factor: 23.059

2.  Chlamydial colonization of multiple mucosae following infection by any mucosal route.

Authors:  L L Perry; S Hughes
Journal:  Infect Immun       Date:  1999-07       Impact factor: 3.441

3.  Correlations between antibody immune responses at different mucosal effector sites are controlled by antigen type and dosage.

Authors:  D Externest; B Meckelein; M A Schmidt; A Frey
Journal:  Infect Immun       Date:  2000-07       Impact factor: 3.441

4.  Quantitative analysis of inflammatory cells infiltrating the cystic fibrosis airway mucosa.

Authors:  C Hubeau; M Lorenzato; J P Couetil; D Hubert; D Dusser; E Puchelle; D Gaillard
Journal:  Clin Exp Immunol       Date:  2001-04       Impact factor: 4.330

5.  Circulating immunoglobulin A- and immunoglobulin G-secreting hybridoma cells in peripheral blood preferably migrate to female genital tracts. The role of sex hormones.

Authors:  Xiaolei Wang; Xudong Zhao; Kunlong Ben; Xiaomei Cao; Yuqi Wang; Hongming Zhou
Journal:  Immunology       Date:  2002-07       Impact factor: 7.397

6.  T lymphocytes in the intestinal epithelium and lamina propria of mice.

Authors:  M R McDermott; P Horsewood; D A Clark; J Bienenstock
Journal:  Immunology       Date:  1986-02       Impact factor: 7.397

7.  Protective humoral response against pneumococcal infection in mice elicited by recombinant bacille Calmette-Guérin vaccines expressing pneumococcal surface protein A.

Authors:  S Langermann; S R Palaszynski; J E Burlein; S Koenig; M S Hanson; D E Briles; C K Stover
Journal:  J Exp Med       Date:  1994-12-01       Impact factor: 14.307

8.  Immunologically mediated intestinal mastocytosis in Nippostrongylus brasiliensis-infected rats.

Authors:  A D Befus; J Bienenstock
Journal:  Immunology       Date:  1979-09       Impact factor: 7.397

9.  Cervical antibodies in patients with oral herpes simplex virus type 1 (HSV-1) infection: local anamnestic responses after genital HSV-2 infection.

Authors:  R Ashley; A Wald; L Corey
Journal:  J Virol       Date:  1994-08       Impact factor: 5.103

10.  The gut as an inductive site for synovial and extra-articular immune responses in rheumatoid arthritis.

Authors:  C Trollmo; C Sollerman; H Carlsten; A Tarkowski
Journal:  Ann Rheum Dis       Date:  1994-06       Impact factor: 19.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.